The susceptibilities of 270 clinical isolates of Pseudomonas aeruginosa from diverse sources (82 burn patients, 76 cystic fibrosis [CF] patients, and 112 other sources) to ciprofloxacin and three other quinolones, nine extended-spectrum beta-lactams, and three aminoglycosides were determined by an agar dilution method in cation-supplemented Mueller-Hinton medium. Ciprofloxacin, ceftazidime, imipenem, and aztreonam were the most active. MICs for burn isolates were consistently higher than those for other isolates for most antibiotics, whereas those for CF strains were consistently lower. Multidrug resistance to aminoglycosides and betalactams occurred in 21% of the burn isolates, 2.6% of the CF isolates, and 8.9% of the other isolates. Ninety percent of these strains remained susceptible to ciprofloxacin. Seven percent of the isolates were resistant to ciprofloxacin (MIC, .2 ,ug/ml). Concurrent resistance to ciprofloxacin and beta-lactams or aminoglycosides was rare (1.8 to 4%). Analysis by Spearman rank correlation revealed a high degree of correlation of MICs among antibiotics within the same class, except for imipenem. An inoculum effect was observed for all antibiotics between 106 and 104 CFU (P < 0.05), with those for piperacillin and cefoperazone being the most pronounced (16-fold and 8-fold differences, respectively), and was least apparent for the quinolones, aminoglycosides, imipenem, and aztreonam (twofold differences). Selected strains for which there were high MICs of ciprofloxacin (.1 ,ug/ml) were tested against ciprofloxacin in combination with other agents in a checkerboard agar dilution assay. Synergistic (summated fractional inhibitory concentration, c0.5) interactions at clinically achievable concentrations were most frequent with mezlocillin (33%), piperacillin (21%), and cefoperazone (17%), less frequent with ceftazidime and imipenem (12% each), and infrequent with cefsulodin (7.6%), aztreonam (3.7%), and the aminoglycosides (3.7%). Antagonism (summated fractional inhibitory concentration, -4) was observed in only one instance (with gentamicin).
Ciprofloxacin, a DNA gyrase inhibitor, is among the most active fluoroquinolones, with broad-spectrum activity in vitro against both gram-positive and gram-negative bacteria (7, 12, 29) . Its activity against Pseutdomonas aeruiginosa, however, is less consistent, and resistance has been encountered, particularly during therapy (2, 11, 22, 23) . In this study, we examined the in vitro activity of ciprofloxacin by an agar dilution method against 270 clinical isolates of P. aeruginosa from various sources, including isolates from cystic fibrosis (CF) patients and burn wound isolates with multidrug resistance. Comparative activity and cross-resistance were determined with three other quinolones, nine antipseudomonal beta-lactams, and three aminoglycosides. The potential effects of inoculum density on their in vitro activities were also compared. Finally, selected strains with high MICs of ciprofloxacin were tested for possible synergy of ciprofloxacin in combination with other agents by a checkerboard agar dilution technique. Demonstration of synergistic activity in vitro with these antimicrobial combinations may suggest useful therapeutic regimens for multidrug-resistant P. aeruginosa infections and for preventing the emergence of resistance during therapy. MATERIALS all within the expected ranges for each antibiotic and did not vary more than one twofold dilution in 10 separate experiments. Overall, the most potent agents were the quinolones, among which ciprofloxacin was the most active and difloxacin was the least active. Among the extended-spectrum beta-lactams, imipenem, aztreonam, ceftazidime, and cefsulodin were the most active agents. The penem S-34343 was inactive against these isolates. Not surprisingly, amikacin was the most active agent among the aminoglycosides. Isolates from burn wounds and from CF patients were separately analyzed (Table 1) . The MICs for burn isolates were consistently higher than for other isolates for all antibiotics except ceftazidime, cefoperazone, ticaricillin, carbenicillin, imipenem, and S-34343 (P < 0.05, rank sum test, two tailed). Similarly, CF isolates were consistently more sensitive than other isolates to all antibiotics except ciprofloxacin, A-56620, and imipenem (P < 0.05, rank sum test). The MICs of all antibiotics were significantly higher when tested with an inoculum of 106 CFU than with an inoculum of 104 CFU (P < 0.05, Wilcoxon signed rank test, two tailed). However, the effect of inoculum density was most prominent for piperacillin and cefoperazone (16-fold and 8-fold differences, respectively), intermediate for difloxacin, ceftazidime, cefsulodin, ticarcillin, and amikacin (three-to fourfold differences), and least apparent for ciprofloxacin, norfloxacin, A-56620, imipenem, aztreonam, carbenicillin, gentamicin, and tobramycin (twofold differences) ( Table 1 ). The inoculum effect for S-34343 could not be accurately determined since most strains were highly resistant at either inoculum density.
The relationships between different antibiotic pairs with respect to their activities against the 270 P. aerigingvosa isolates were examined by Spearman rank correlation ( Only 11 of the 120 correlation coefficients showed values less than 0.16 (all in imipenem combinations) and therefore were not statistically significant at the 1% level (P < 0.01). In general, high correlation coefficients were observed among agents within the same antibiotic class (i.e., quinolones, aminoglycosides, or beta-lactams). There was a high degree of intercorrelation among the penicillins, cephalosporins, and aztreonam (r 2 0.5) but not the penems (Table 2) . Piperacillin also demonstrated moderate correlation with gentamicin and tobramycin (r 0.5). Ciprofloxacin correlated poorly with the beta-lactams or aminoglycosides. Imipenem demonstrated the least correlation with all other agents tested.
Twenty-nine of the 270 isolates were found to be resistant to both gentamicin (MIC, .6 ,ug/ml) and piperacillin (MIC, .128 [Lg/ml) and were separately analyzed ( Our data are unique in that a relatively large number of clinical isolates were tested and results were analyzed according to the patient population from which they were isolated, including burn wound and CF patients. These data also demonstrate the frequency of multidrug resistance of P. aeruginosa isolates from our burn unit. Importantly, these isolates remained susceptible to ciprofloxacin, although the MICs of this agent were also significantly higher than those Table 3 ; the breakpoint for mezlocillin was 64 ,ug/ml).
for non-burn isolates. CF isolates remained highly susceptible to ciprofloxacin, as was reported by Klinger and Aronoff (22) and Bosso et al. (3). Interestingly, in contrast to other agents tested, no significant difference in MICs of ciprofloxacin was noted in our study between CF and non-CF isolates.
Using cation-supplemented Mueller-Hinton agar, we demonstrated a significant effect of inoculum density on the MICs for all agents tested, although this was less apparent for the quinolones, aminoglycosides, imipenem, and aztreonam than for other beta-lactam agents. The inoculum effect was most prominent for piperacillin and cefoperazone. Eng et al. (14) reported similar findings and described three groups of antipseudomonal agents according to their inoculum effect and antibacterial activity: group I antibiotics (typified by piperacillin and cefoperazone) demonstrated the largest inoculum effect, were poorly bactericidal, and produced aberrant, elongated bacilli during antibiotic exposure; group II antibiotics (typified by ceftazidime and ticarcillin) demonstrated moderate inoculum effect, were slowly bactericidal, and caused minimal formation of aberrant, elongated bacilli; and group III antibiotics (typified by imipenem and tobramycin) were bactericidal and did not cause the formation of elongated bacilli and regrowth. Our data suggest that quinolones, particularly ciprofloxacin, belong in the group III category of antibiotics against P. aeruginosa.
It has been reported by several investigators that the cation concentration and type of medium used for susceptibility testing greatly influence the in vitro activities of the quinolones, aminoglycosides, and extended-spectrum betalactams against P. aeruginosa (9, 15, 19, 30) . We supplemented the test medium in our studies since the lot of Mueller-Hinton agar we used was low in calcium and magnesium and required supplementation to attain physiologic concentrations (calcium, 2.25 to 2.75 mM; magnesium, 0.75 to 1.25 nM). We believe that it is prudent to routinely determine the calcium and magnesium concentrations of the medium to be used to appropriately assess the need for supplementation, since variation in media between lots and from different manufacturers is not uncommon (26) .
The occurrence of cross-resistance or concurrent resistance of P. aeruginosa to related or unrelated antibiotics has not been studied extensively. Without identifying the mechanisms of resistance, it is impossible to determine whether true cross-resistance to two agents is present. Our analysis by the Spearman rank correlation technique indicates a high degree of correlation among antibiotics within the same class (i.e., quinolones, extended-spectrum beta-lactams, or aminoglycosides) and suggests that cross-resistance to these agents might be present. Multidrug resistance to gentamicin and piperacillin, as well as to tobramycin, aztreonam, and extended-spectrum cephalosporins, was found in approximately 10% of our isolates. Importantly, these strains remained susceptible to ciprofloxacin. Coresistance to ciprofloxacin and aminoglycosides (1.8 to 4% of strains), imipenem (3%), or other extended-spectrum beta-lactams (0.7 to 4%) was observed infrequently. Multidrug resistance involving ciprofloxacin, imipenem, ceftazidime, and aminoglycosides was not found. Selection of multidrug resistance to quinolones, beta-lactams, and aminoglycosides is being increasingly recognized among nosocomial pathogens (27) . These data underscore the need to examine carefully the frequency with which resistance to any new antibiotic develops, as well as the patterns of multidrug resistance which may occur simultaneously. Such determinations are particularly important in areas of high selection pressure due to intensive antimicrobial use, such as burn and intensive care units, and among CF patients.
Since 7% of our strains were resistant to ciprofloxacin and multidrug resistance to aminoglycosides and extended-spectrum beta-lactams was not infrequent, the activity of ciprofloxacin in combination with other agents was of particular interest. Synergy was most frequent with mezlocillin (33%) and piperacillin (21%), moderately frequent with cefoperazone, ceftazidime, and imipenem (12 to 16%), and least frequent with aztreonam and aminoglycosides (3.7%). Similar data have been obtained by other investigators using either the checkerboard microdilution technique or the timekill curve method (4, 5, 8, 16-18, 21, 24) . In addition to synergistic interactions of ciprofloxacin with mezlocillin and piperacillin, frequent synergistic interactions of ciprofloxacin with azlocillin against P. aeruginosa have been noted by other workers both in vitro and in vivo (21, 24) . The mechanism(s) responsible for the enhanced activity of these agents in combination are presently unknown. Several investigators have pointed out the relative lack of agreement between the checkerboard and time-kill curve techniques in demonstrating antimicrobial synergy against pseudomonads (6, 18, 24) . These differences could be due to variations in media, including divalent cation content, or to the selection and regrowth of aberrant forms of P. aeruginosa, which can be more readily demonstrated in broth during the time-kill assay than in an agar medium. Nevertheless, the in vitro data demonstrating synergistic but not antagonistic interactions with ciprofloxacin combinations suggest that these agents may prove useful for the management of multidrug-resistant P. aeruginosa infections. Combination therapy with ciprofloxacin may also deter the emergence of resistance, as has been demonstrated in earlier studies (23 
